Skip to main content
Top
Published in: Journal of Inflammation 1/2010

Open Access 01-12-2010 | Research

Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite,5-(p-hydroxyphenyl-), 5-phenylhydantoin

Authors: Ryan Serra, Abdel-ghany Al-saidi, Nikola Angelov, Salvador Nares

Published in: Journal of Inflammation | Issue 1/2010

Login to get access

Abstract

Background

Phenytoin (PHT) has been reported to induce gingival (gum) overgrowth (GO) in approximately 50% of patients taking this medication. While most studies have focused on the effects of PHT on the fibroblast in the pathophysiology underlying GO, few studies have investigated the potential regulatory role of macrophages in extracellular matrix (ECM) turnover and secretion of proinflammatory mediators. The aim of this study was to evaluate the effects of PHT and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin (HPPH) on LPS-elicited MMP, TIMP, TNF-α and IL-6 levels in macrophages.

Methods

Human primary monocyte-derived macrophages (n = 6 independent donors) were pretreated with 15-50 μg/mL PHT-Na+ or 15-50 μg/mL HPPH for 1 hour. Cells were then challenged with 100 ng/ml purified LPS from the periodontal pathogen, Aggregatibacter actinomycetemcomitans. Supernatants were collected after 24 hours and levels of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12, TIMP-1, TIMP-2, TIMP-3, TIMP-4, TNF-α and IL-6 determined by multiplex analysis or enzyme-linked immunoadsorbent assay.

Results

A dose-dependent inhibition of MMP-1, MMP-3, MMP-9, TIMP-1 but not MMP-2 was noted in culture supernatants pretreated with PHT or HPPH prior to LPS challenge. MMP-12, TIMP-2, TIMP-3 and TIMP-2 were not detected in culture supernatants. High concentrations of PHT but not HPPH, blunted LPS-induced TNF-α production although neither significantly affected IL-6 levels.

Conclusion

The ability of macrophages to mediate turnover of ECM via the production of metalloproteinases is compromised not only by PHT, but its metabolite, HPPH in a dose-dependent fashion. Further, the preferential dysregulation of macrophage-derived TNF-α but not IL-6 in response to bacterial challenge may provide an inflammatory environment facilitating collagen accumulation without the counteracting production of MMPs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dongari-Bagtzoglou A: Informational paper: Drug-associated gingival enlargement. J Periodontol. 2004, 75: 1424-1431. 10.1902/jop.2004.75.10.1424.PubMedCrossRef Dongari-Bagtzoglou A: Informational paper: Drug-associated gingival enlargement. J Periodontol. 2004, 75: 1424-1431. 10.1902/jop.2004.75.10.1424.PubMedCrossRef
2.
go back to reference Penarrocha-Diago M, Bagan-Sebastian JV, Vera-Sempere F: Diphenylhydantoin-induced gingival overgrowth in man: a clinicopathological study. J Periodontol. 1990, 61: 571-574.PubMedCrossRef Penarrocha-Diago M, Bagan-Sebastian JV, Vera-Sempere F: Diphenylhydantoin-induced gingival overgrowth in man: a clinicopathological study. J Periodontol. 1990, 61: 571-574.PubMedCrossRef
3.
go back to reference Pincus HH: Diphenyldantoin and ion flux in lobster nerve. Arch Neur. 1972, 26: 4-10.CrossRef Pincus HH: Diphenyldantoin and ion flux in lobster nerve. Arch Neur. 1972, 26: 4-10.CrossRef
4.
go back to reference Bajpai M, Roskos LK, Shen DD, Levy RH: Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos. 1996, 24: 1401-1403.PubMed Bajpai M, Roskos LK, Shen DD, Levy RH: Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite. Drug Metab Dispos. 1996, 24: 1401-1403.PubMed
5.
go back to reference Lin CJ, Yen MF, Hu OY, Lin MS, Hsiong CH, Liou HH: Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy. Pharmacotherapy. 2008, 28: 35-41. 10.1592/phco.28.1.35.PubMedCrossRef Lin CJ, Yen MF, Hu OY, Lin MS, Hsiong CH, Liou HH: Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy. Pharmacotherapy. 2008, 28: 35-41. 10.1592/phco.28.1.35.PubMedCrossRef
6.
go back to reference Ieiri I, Goto W, Hirata K, Toshitani A, Imayama S, Ohyama Y, Yamada H, Ohtsubo K, Higuchi S: Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study. Eur J Clin Pharmacol. 1995, 49: 51-56. 10.1007/BF00192358.PubMedCrossRef Ieiri I, Goto W, Hirata K, Toshitani A, Imayama S, Ohyama Y, Yamada H, Ohtsubo K, Higuchi S: Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study. Eur J Clin Pharmacol. 1995, 49: 51-56. 10.1007/BF00192358.PubMedCrossRef
7.
go back to reference Seymour RA, Ellis JS, Thomason JM: Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000, 27: 217-223. 10.1034/j.1600-051x.2000.027004217.x.PubMedCrossRef Seymour RA, Ellis JS, Thomason JM: Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000, 27: 217-223. 10.1034/j.1600-051x.2000.027004217.x.PubMedCrossRef
8.
go back to reference Seymour RA, Thomason JM, Ellis JS: The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol. 1996, 23: 165-175. 10.1111/j.1600-051X.1996.tb02072.x.PubMedCrossRef Seymour RA, Thomason JM, Ellis JS: The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol. 1996, 23: 165-175. 10.1111/j.1600-051X.1996.tb02072.x.PubMedCrossRef
9.
go back to reference Abergel RP, Meeker CA, Lam TS, Dwyer RM, Lesavoy MA, Uitto J: Control of connective tissue metabolism by lasers. Recent developments and future prospects. J Amer Acad Dermatol. 1984, 11: 1142-1150. 10.1016/S0190-9622(84)80194-2.CrossRef Abergel RP, Meeker CA, Lam TS, Dwyer RM, Lesavoy MA, Uitto J: Control of connective tissue metabolism by lasers. Recent developments and future prospects. J Amer Acad Dermatol. 1984, 11: 1142-1150. 10.1016/S0190-9622(84)80194-2.CrossRef
10.
go back to reference Hassell TM, Page RC, Narayanan AS, Cooper CG: Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Proc Natl Acad Sci USA. 1976, 73: 2909-2912. 10.1073/pnas.73.8.2909.PubMedPubMedCentralCrossRef Hassell TM, Page RC, Narayanan AS, Cooper CG: Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Proc Natl Acad Sci USA. 1976, 73: 2909-2912. 10.1073/pnas.73.8.2909.PubMedPubMedCentralCrossRef
11.
go back to reference Iacopino A, Doxey D, Cutler C, Nares S, Stoever K, Fojt J, Gonzales A, Dill RE: Phenytoin and cyclosporine A specifically regulate macrophage phenytoin and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol. 1997, 68: 73-83.PubMedCrossRef Iacopino A, Doxey D, Cutler C, Nares S, Stoever K, Fojt J, Gonzales A, Dill RE: Phenytoin and cyclosporine A specifically regulate macrophage phenytoin and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol. 1997, 68: 73-83.PubMedCrossRef
12.
go back to reference Nares S, Wahl SM: Monocytes and Macrophages. Measuring Immunity: Basic Science and Clinical Practice. Edited by: Lotze MT, Thomson AT. 2005, London: Elsevier, 299-311. 1CrossRef Nares S, Wahl SM: Monocytes and Macrophages. Measuring Immunity: Basic Science and Clinical Practice. Edited by: Lotze MT, Thomson AT. 2005, London: Elsevier, 299-311. 1CrossRef
13.
go back to reference Riches DW: The multiple roles of macrophages in wound healing. The Molecular and Cellular Biology of Wound Repair. Edited by: Clark RAF, Henson PM. 1988, New York: Plenum Press, 213-239.CrossRef Riches DW: The multiple roles of macrophages in wound healing. The Molecular and Cellular Biology of Wound Repair. Edited by: Clark RAF, Henson PM. 1988, New York: Plenum Press, 213-239.CrossRef
14.
go back to reference Andreesen R, Brugger W, Scheinenbogen C: Surface phenotype analysis of human monocyte to macrophage differentiation. J Leuk Biol. 1990, 47: 490-497. Andreesen R, Brugger W, Scheinenbogen C: Surface phenotype analysis of human monocyte to macrophage differentiation. J Leuk Biol. 1990, 47: 490-497.
15.
go back to reference Messadi DV, Bertolami CN: General principles of healing pertinent to the periodontal problem. Dent Clin North Am. 1991, 35: 443-457.PubMed Messadi DV, Bertolami CN: General principles of healing pertinent to the periodontal problem. Dent Clin North Am. 1991, 35: 443-457.PubMed
16.
go back to reference Martin P, Hopkins-Woolley J, McCluskey J: Growth factors and cutaneous wound repair. Prog Growth Factor Res. 1992, 4: 25-44. 10.1016/0955-2235(92)90003-Z.PubMedCrossRef Martin P, Hopkins-Woolley J, McCluskey J: Growth factors and cutaneous wound repair. Prog Growth Factor Res. 1992, 4: 25-44. 10.1016/0955-2235(92)90003-Z.PubMedCrossRef
17.
go back to reference Kreutz M, Krause SW, Rehm A: Macrophage heterogeneity and differentiation. Pres Immunol. 1992, 143: 107-115. 10.1016/0923-2494(92)80087-2.CrossRef Kreutz M, Krause SW, Rehm A: Macrophage heterogeneity and differentiation. Pres Immunol. 1992, 143: 107-115. 10.1016/0923-2494(92)80087-2.CrossRef
18.
go back to reference Wikesjo UME, Nilveus RE, Selvig KA: Significance of early healing events on periodontal repair: a review. J Periodontol. 1992, 63: 158-165. 10.1902/jop.1992.63.3.158.PubMedCrossRef Wikesjo UME, Nilveus RE, Selvig KA: Significance of early healing events on periodontal repair: a review. J Periodontol. 1992, 63: 158-165. 10.1902/jop.1992.63.3.158.PubMedCrossRef
19.
go back to reference Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM: Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol. 1996, 67: 271-278.PubMedCrossRef Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM: Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol. 1996, 67: 271-278.PubMedCrossRef
20.
go back to reference Nares S, Moutsopoulos NM, Angelov N, Rangel ZG, Munson PJ, Sinha N, Wahl SM: Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis. Am J Pathol. 2009, 174: 1400-1414. 10.2353/ajpath.2009.080677.PubMedPubMedCentralCrossRef Nares S, Moutsopoulos NM, Angelov N, Rangel ZG, Munson PJ, Sinha N, Wahl SM: Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis. Am J Pathol. 2009, 174: 1400-1414. 10.2353/ajpath.2009.080677.PubMedPubMedCentralCrossRef
21.
go back to reference Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG, Munson PJ, Wahl SM: Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood. 2007, 110: 393-400. 10.1182/blood-2006-10-051763.PubMedPubMedCentralCrossRef Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG, Munson PJ, Wahl SM: Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood. 2007, 110: 393-400. 10.1182/blood-2006-10-051763.PubMedPubMedCentralCrossRef
22.
go back to reference Vajda FJE: The value of phenytoin plasma levels in the treatment of epilepsy. Med J Aust. 1970, 2: 1074-1076.PubMed Vajda FJE: The value of phenytoin plasma levels in the treatment of epilepsy. Med J Aust. 1970, 2: 1074-1076.PubMed
23.
go back to reference Hvidberg EI, Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet. 1976, 1: 161-188. 10.2165/00003088-197601030-00001.PubMedCrossRef Hvidberg EI, Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet. 1976, 1: 161-188. 10.2165/00003088-197601030-00001.PubMedCrossRef
24.
go back to reference Eadie MJ: Plasma level monitoring of anticonvulsants. Clin Pharmacokinet. 1976, 1: 52-66. 10.2165/00003088-197601010-00005.PubMedCrossRef Eadie MJ: Plasma level monitoring of anticonvulsants. Clin Pharmacokinet. 1976, 1: 52-66. 10.2165/00003088-197601010-00005.PubMedCrossRef
25.
go back to reference Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, Wu CH: Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci. 2005, 1042: 262-271. 10.1196/annals.1338.030.PubMedCrossRef Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, Wu CH: Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci. 2005, 1042: 262-271. 10.1196/annals.1338.030.PubMedCrossRef
26.
go back to reference Rival Y, Benéteau N, Chapuis V, Taillandier T, Lestienne F, Dupont-Passelaigue E, Patoiseau JF, Colpaert FC, Junquéro D: Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages. DNA Cell Biol. 2004, 23: 283-292. 10.1089/104454904323090912.PubMedCrossRef Rival Y, Benéteau N, Chapuis V, Taillandier T, Lestienne F, Dupont-Passelaigue E, Patoiseau JF, Colpaert FC, Junquéro D: Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages. DNA Cell Biol. 2004, 23: 283-292. 10.1089/104454904323090912.PubMedCrossRef
27.
go back to reference Rossa C, Liu M, Bronson P, Kirkwood KL: Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase. J Endotoxin Res. 2007, 13: 85-93. 10.1177/0968051907079118.PubMedCrossRef Rossa C, Liu M, Bronson P, Kirkwood KL: Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase. J Endotoxin Res. 2007, 13: 85-93. 10.1177/0968051907079118.PubMedCrossRef
28.
go back to reference Bodet C, Chandad F, Grenier D: Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infec. 2006, 8: 27-35. 10.1016/j.micinf.2005.05.015.CrossRef Bodet C, Chandad F, Grenier D: Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infec. 2006, 8: 27-35. 10.1016/j.micinf.2005.05.015.CrossRef
29.
go back to reference Woo CH, Lim JH, Kim JH: Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol. 2004, 173: 6973-6980.PubMedCrossRef Woo CH, Lim JH, Kim JH: Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol. 2004, 173: 6973-6980.PubMedCrossRef
30.
go back to reference Zhang Y, Mc Cluskey K, Fujii K, Wahl L: Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol. 1998, 161: 3071-3076.PubMed Zhang Y, Mc Cluskey K, Fujii K, Wahl L: Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol. 1998, 161: 3071-3076.PubMed
31.
go back to reference Trackman PC, Kantarci A: Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med. 2004, 4: 165-175. 10.1177/154411130401500305.CrossRef Trackman PC, Kantarci A: Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med. 2004, 4: 165-175. 10.1177/154411130401500305.CrossRef
32.
go back to reference Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila ML: Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication. J Periodontol. 2002, 73: 1323-1330. 10.1902/jop.2002.73.11.1323.PubMedCrossRef Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila ML: Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication. J Periodontol. 2002, 73: 1323-1330. 10.1902/jop.2002.73.11.1323.PubMedCrossRef
33.
go back to reference Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M, Laher MH: Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol. 2000, 27: 506-512. 10.1034/j.1600-051x.2000.027007506.x.PubMedCrossRef Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M, Laher MH: Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol. 2000, 27: 506-512. 10.1034/j.1600-051x.2000.027007506.x.PubMedCrossRef
34.
go back to reference Akiyama S, Amano A, Kato T, Takada Y, Kimura KR, Morisaki I: Relationship of periodontal bacteria and Porphyromonas gingivalis fimA variations with phenytoin-induced gingival overgrowth. Oral Dis. 2006, 12: 51-56. 10.1111/j.1601-0825.2005.01157.x.PubMedCrossRef Akiyama S, Amano A, Kato T, Takada Y, Kimura KR, Morisaki I: Relationship of periodontal bacteria and Porphyromonas gingivalis fimA variations with phenytoin-induced gingival overgrowth. Oral Dis. 2006, 12: 51-56. 10.1111/j.1601-0825.2005.01157.x.PubMedCrossRef
35.
go back to reference La VD, Bergeron C, Gafner S, Grenier D: Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and -9 activities. J Periodontol. 2009, 80: 1875-1882. 10.1902/jop.2009.090251.PubMedCrossRef La VD, Bergeron C, Gafner S, Grenier D: Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and -9 activities. J Periodontol. 2009, 80: 1875-1882. 10.1902/jop.2009.090251.PubMedCrossRef
36.
go back to reference Güncü GN, Caglayan F, Dinçel A, Bozkurt A, Saygi S, Karabulut E: Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth. J Periodontol. 2006, 77: 2005-2010. 10.1902/jop.2006.060103.PubMedCrossRef Güncü GN, Caglayan F, Dinçel A, Bozkurt A, Saygi S, Karabulut E: Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth. J Periodontol. 2006, 77: 2005-2010. 10.1902/jop.2006.060103.PubMedCrossRef
37.
go back to reference Ryan ME, Golub LM: Modulation of matrix metalloproteinase activities in periodontitis as a treatment of strategy. J Periodontol. 2000, 24: 226-238. 10.1034/j.1600-0757.2000.2240111.x.CrossRef Ryan ME, Golub LM: Modulation of matrix metalloproteinase activities in periodontitis as a treatment of strategy. J Periodontol. 2000, 24: 226-238. 10.1034/j.1600-0757.2000.2240111.x.CrossRef
38.
go back to reference Sukkar TZ, Thomason JM, Cawston TE, Lakey R, Jones D, Catterall J, Seymour RA: Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines. J Periodontal Res. 2007, 42: 580-588. 10.1111/j.1600-0765.2007.00986.x.PubMedCrossRef Sukkar TZ, Thomason JM, Cawston TE, Lakey R, Jones D, Catterall J, Seymour RA: Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines. J Periodontal Res. 2007, 42: 580-588. 10.1111/j.1600-0765.2007.00986.x.PubMedCrossRef
39.
go back to reference Sugano N, Ito K, Murai S: Cyclosporin A inhibits collagenase gene expression via AP-1 and JNK suppression in human gingival fibroblasts. J Periodontal Res. 1998, 33: 448-452. 10.1111/j.1600-0765.1998.tb02343.x.PubMedCrossRef Sugano N, Ito K, Murai S: Cyclosporin A inhibits collagenase gene expression via AP-1 and JNK suppression in human gingival fibroblasts. J Periodontal Res. 1998, 33: 448-452. 10.1111/j.1600-0765.1998.tb02343.x.PubMedCrossRef
40.
go back to reference Bolzani G, Della Coletta R, Martelli Júnior H, Martelli Júnior H, Graner E: Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodontal Res. 2000, 35: 51-58. 10.1034/j.1600-0765.2000.035001051.x.PubMedCrossRef Bolzani G, Della Coletta R, Martelli Júnior H, Martelli Júnior H, Graner E: Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodontal Res. 2000, 35: 51-58. 10.1034/j.1600-0765.2000.035001051.x.PubMedCrossRef
41.
go back to reference Kataoka M, Shimizu Y, Kunikiyo K, Asahara Y, Yamashita K, Ninomiya M, Morisaki I, Ohsaki Y, Kido JI, Nagata T: Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol. 2000, 182: 351-358. 10.1002/(SICI)1097-4652(200003)182:3<351::AID-JCP5>3.0.CO;2-U.PubMedCrossRef Kataoka M, Shimizu Y, Kunikiyo K, Asahara Y, Yamashita K, Ninomiya M, Morisaki I, Ohsaki Y, Kido JI, Nagata T: Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol. 2000, 182: 351-358. 10.1002/(SICI)1097-4652(200003)182:3<351::AID-JCP5>3.0.CO;2-U.PubMedCrossRef
42.
go back to reference Yamada H, Nishimura F, Naruishi K, Chou HH, Takashiba S, Albright GM, Nares S, Iacopino AM, Murayama Y: Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol. 2000, 71: 955-960. 10.1902/jop.2000.71.6.955.PubMedCrossRef Yamada H, Nishimura F, Naruishi K, Chou HH, Takashiba S, Albright GM, Nares S, Iacopino AM, Murayama Y: Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol. 2000, 71: 955-960. 10.1902/jop.2000.71.6.955.PubMedCrossRef
43.
go back to reference Hyland PL, Traynor PS, Myrillas TT, Marley JJ, Linden GJ, Winter P, Leadbetter N, Cawston TE, Irwin CR: The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol. 2003, 74: 437-445. 10.1902/jop.2003.74.4.437.PubMedCrossRef Hyland PL, Traynor PS, Myrillas TT, Marley JJ, Linden GJ, Winter P, Leadbetter N, Cawston TE, Irwin CR: The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol. 2003, 74: 437-445. 10.1902/jop.2003.74.4.437.PubMedCrossRef
44.
go back to reference McGaw T, Lam S, Coates J: Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol. 1987, 64: 293-297. 10.1016/0030-4220(87)90007-7.PubMedCrossRef McGaw T, Lam S, Coates J: Cyclosporin-induced gingival overgrowth: correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol. 1987, 64: 293-297. 10.1016/0030-4220(87)90007-7.PubMedCrossRef
45.
go back to reference Pan WL, Chan CP, Huang CC, Lai MK: Cyclosporine-induced gingival overgrowth. Transplant Proc. 1992, 24: 1393-1394.PubMed Pan WL, Chan CP, Huang CC, Lai MK: Cyclosporine-induced gingival overgrowth. Transplant Proc. 1992, 24: 1393-1394.PubMed
46.
go back to reference Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML: Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol. 1992, 63: 548-553.PubMedCrossRef Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML: Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol. 1992, 63: 548-553.PubMedCrossRef
47.
go back to reference King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DM, Wiesenfeld D: Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol. 1993, 20: 286-293. 10.1111/j.1600-051X.1993.tb00360.x.PubMedCrossRef King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DM, Wiesenfeld D: Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol. 1993, 20: 286-293. 10.1111/j.1600-051X.1993.tb00360.x.PubMedCrossRef
48.
go back to reference O'Valle F, Mesa FL, Gómez-Morales M, Aguilar D, Caracuel MD, Medina-Cano MT, Andújar M, López-Hidalgo J, García del Moral R: Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. J Periodontol. 1994, 65: 724-730.PubMedCrossRef O'Valle F, Mesa FL, Gómez-Morales M, Aguilar D, Caracuel MD, Medina-Cano MT, Andújar M, López-Hidalgo J, García del Moral R: Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. J Periodontol. 1994, 65: 724-730.PubMedCrossRef
49.
go back to reference Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR: Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol. 1995, 66: 742-746.PubMedCrossRef Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR: Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol. 1995, 66: 742-746.PubMedCrossRef
50.
go back to reference Emingil G, Afacan B, Tervahartiala T, Toz H, Atilla G, Sorsa T: Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy. J Clin Periodontol. 2008, 35: 221-229. 10.1111/j.1600-051X.2007.01192.x.PubMedCrossRef Emingil G, Afacan B, Tervahartiala T, Toz H, Atilla G, Sorsa T: Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy. J Clin Periodontol. 2008, 35: 221-229. 10.1111/j.1600-051X.2007.01192.x.PubMedCrossRef
51.
go back to reference Gagliano N, Moscheni C, Dellavia C, Stabellini G, Ferrario VF, Gioia M: Immunosuppression and gingival overgrowth: gene and protein expression profiles of collagen turnover in FK506-treated human gingival fibroblasts. J Clin Periodontol. 2005, 32: 167-173. 10.1111/j.1600-051X.2005.00654.x.PubMedCrossRef Gagliano N, Moscheni C, Dellavia C, Stabellini G, Ferrario VF, Gioia M: Immunosuppression and gingival overgrowth: gene and protein expression profiles of collagen turnover in FK506-treated human gingival fibroblasts. J Clin Periodontol. 2005, 32: 167-173. 10.1111/j.1600-051X.2005.00654.x.PubMedCrossRef
52.
go back to reference Domeij H, Yucel-Lindberg T, Modéer T: Cell interactions between human gingival fibroblasts and monocytes stimulate the production of matrix metalloproteinase-1 in gingival fibroblasts. J Periodontal Res. 2006, 41: 108-117. 10.1111/j.1600-0765.2005.00840.x.PubMedCrossRef Domeij H, Yucel-Lindberg T, Modéer T: Cell interactions between human gingival fibroblasts and monocytes stimulate the production of matrix metalloproteinase-1 in gingival fibroblasts. J Periodontal Res. 2006, 41: 108-117. 10.1111/j.1600-0765.2005.00840.x.PubMedCrossRef
53.
go back to reference Black JA, Liu S, Waxman SG: Sodium channel activity modulates multiple functions in microglia. Glia. 2009, 57: 1072-1081. 10.1002/glia.20830.PubMedCrossRef Black JA, Liu S, Waxman SG: Sodium channel activity modulates multiple functions in microglia. Glia. 2009, 57: 1072-1081. 10.1002/glia.20830.PubMedCrossRef
54.
go back to reference Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, Newcombe J, Cuzner ML, Waxman SG: Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia. 2005, 49: 220-229. 10.1002/glia.20112.PubMedCrossRef Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, Newcombe J, Cuzner ML, Waxman SG: Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia. 2005, 49: 220-229. 10.1002/glia.20112.PubMedCrossRef
55.
go back to reference Roselli F, Livrea P, Jirillo E: Voltage-gated sodium channel blockers as immunomodulators. Recent Patents CNS Drug Disc. 2006, 1: 83-91. 10.2174/157488906775245255.CrossRef Roselli F, Livrea P, Jirillo E: Voltage-gated sodium channel blockers as immunomodulators. Recent Patents CNS Drug Disc. 2006, 1: 83-91. 10.2174/157488906775245255.CrossRef
56.
go back to reference Suzuki AM, Yoshimura A, Ozaki Y, Kaneko T, Hara Y: Cyclosporin A and phenytoin modulate inflammatory responses. J Dent Res. 2009, 88: 1131-1136. 10.1177/0022034509350566.PubMedCrossRef Suzuki AM, Yoshimura A, Ozaki Y, Kaneko T, Hara Y: Cyclosporin A and phenytoin modulate inflammatory responses. J Dent Res. 2009, 88: 1131-1136. 10.1177/0022034509350566.PubMedCrossRef
57.
go back to reference Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi T, Udagawa N: Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling. J Bone Miner Res. 2009, 24: 1469-1480. 10.1359/jbmr.090302.PubMedCrossRef Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi T, Udagawa N: Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling. J Bone Miner Res. 2009, 24: 1469-1480. 10.1359/jbmr.090302.PubMedCrossRef
58.
go back to reference Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Krüttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P: The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol. 2009, 104: 435-448. 10.1007/s00395-008-0772-6.PubMedCrossRef Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Krüttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P: The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol. 2009, 104: 435-448. 10.1007/s00395-008-0772-6.PubMedCrossRef
59.
go back to reference Shiozawa S, Tsumiyama K: Pathogenesis of rheumatoid arthritis and c-Fos/AP-1. Cell Cycle. 2009, 8: 1539-1543. 10.4161/cc.8.10.8411.PubMedCrossRef Shiozawa S, Tsumiyama K: Pathogenesis of rheumatoid arthritis and c-Fos/AP-1. Cell Cycle. 2009, 8: 1539-1543. 10.4161/cc.8.10.8411.PubMedCrossRef
60.
go back to reference Clark IM, Swingler TE, Sampieri CL, Edwards DR: The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008, 40: 1362-1378. 10.1016/j.biocel.2007.12.006.PubMedCrossRef Clark IM, Swingler TE, Sampieri CL, Edwards DR: The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008, 40: 1362-1378. 10.1016/j.biocel.2007.12.006.PubMedCrossRef
61.
go back to reference Kobayashi K, Yamagami S, Higuchi T, Hosokawa M, Chiba K: Key structural features of ligands for activation of human pregnane X receptor. Drug Metab Dispos. 2004, 32: 468-472. 10.1124/dmd.32.4.468.PubMedCrossRef Kobayashi K, Yamagami S, Higuchi T, Hosokawa M, Chiba K: Key structural features of ligands for activation of human pregnane X receptor. Drug Metab Dispos. 2004, 32: 468-472. 10.1124/dmd.32.4.468.PubMedCrossRef
62.
go back to reference Ramsden L, Rider CC: Selective and differential binding of interleukin (1L)-1 alpha, IL-1 beta, IL-2, and IL-6 to glycosaminoglycans. Eur J Immunol. 1992, 22: 3027-3031. 10.1002/eji.1830221139.PubMedCrossRef Ramsden L, Rider CC: Selective and differential binding of interleukin (1L)-1 alpha, IL-1 beta, IL-2, and IL-6 to glycosaminoglycans. Eur J Immunol. 1992, 22: 3027-3031. 10.1002/eji.1830221139.PubMedCrossRef
63.
go back to reference Snow AD, Willmer JP, Kisilevsky R: Sulfated glycosaminoglycans in Alzheimer's disease. Hum Pathol. 1987, 18: 506-510. 10.1016/S0046-8177(87)80036-9.PubMedCrossRef Snow AD, Willmer JP, Kisilevsky R: Sulfated glycosaminoglycans in Alzheimer's disease. Hum Pathol. 1987, 18: 506-510. 10.1016/S0046-8177(87)80036-9.PubMedCrossRef
64.
go back to reference Modeer T, Brunius G, Iinuma M, Lerner UH: Phenytoin potentiates interleukin-1 induced prostaglandin biosynthesis in human gingival fibroblasts. Bri J Pharma. 1992, 106: 574-578.CrossRef Modeer T, Brunius G, Iinuma M, Lerner UH: Phenytoin potentiates interleukin-1 induced prostaglandin biosynthesis in human gingival fibroblasts. Bri J Pharma. 1992, 106: 574-578.CrossRef
65.
go back to reference Saren P, Welgus HG, Kovanen PT: TNF-alpha and IL-1b selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996, 157: 4159-4165.PubMed Saren P, Welgus HG, Kovanen PT: TNF-alpha and IL-1b selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996, 157: 4159-4165.PubMed
66.
go back to reference Domeij H, Yucel-Lindberg T, Modeer T: Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci. 2002, 110: 302-306. 10.1034/j.1600-0722.2002.21247.x.PubMedCrossRef Domeij H, Yucel-Lindberg T, Modeer T: Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci. 2002, 110: 302-306. 10.1034/j.1600-0722.2002.21247.x.PubMedCrossRef
67.
go back to reference Birkedal-Hansen H, Moore WG, Bodden MK, Birkedal-Hansen H: Matrix metalloproteinease: a review. Crit Rev Oral Biol Med. 1993, 4: 197-250.PubMed Birkedal-Hansen H, Moore WG, Bodden MK, Birkedal-Hansen H: Matrix metalloproteinease: a review. Crit Rev Oral Biol Med. 1993, 4: 197-250.PubMed
68.
go back to reference Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985, 230: 943-945. 10.1126/science.3933111.PubMedCrossRef Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985, 230: 943-945. 10.1126/science.3933111.PubMedCrossRef
69.
go back to reference Chou DH, Lee W, McCulloch CA: TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis. J Immunol. 1996, 156: 4354-4362.PubMed Chou DH, Lee W, McCulloch CA: TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis. J Immunol. 1996, 156: 4354-4362.PubMed
70.
go back to reference Reunanen N, Li S-P, Ahonen M, Foschi M, Han J, Kahari V-M: Activation of p38alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem. 2002, 277: 32360-32368. 10.1074/jbc.M204296200.PubMedCrossRef Reunanen N, Li S-P, Ahonen M, Foschi M, Han J, Kahari V-M: Activation of p38alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem. 2002, 277: 32360-32368. 10.1074/jbc.M204296200.PubMedCrossRef
71.
go back to reference Srivastava AK, Qin X, Wedhas N, Arnush M, Linkhart TA, Chadwick RB, Kumar A: Tumor necrosis factor-{alpha} augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor--activated kinase 1 (TAK1)-dependent signaling pathway. J Biol Chem. 2007, 282: 35113-35124. 10.1074/jbc.M705329200.PubMedPubMedCentralCrossRef Srivastava AK, Qin X, Wedhas N, Arnush M, Linkhart TA, Chadwick RB, Kumar A: Tumor necrosis factor-{alpha} augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor--activated kinase 1 (TAK1)-dependent signaling pathway. J Biol Chem. 2007, 282: 35113-35124. 10.1074/jbc.M705329200.PubMedPubMedCentralCrossRef
72.
go back to reference Lichtman SN, Wang J, Zhang C, Lemasters JJ: Endocytosis and Ca2+ are required for endotoxin-stimulated TNF-alpha release by rat Kupffer cells. Am J Physiol. 1996, 271: G920-G928.PubMed Lichtman SN, Wang J, Zhang C, Lemasters JJ: Endocytosis and Ca2+ are required for endotoxin-stimulated TNF-alpha release by rat Kupffer cells. Am J Physiol. 1996, 271: G920-G928.PubMed
73.
go back to reference Letari O, Nicosia S, Chiavaroli C, Vacher P, Schlegel W: Activation by bacterial lipopolysaccharide causes changes in the cytosolic free calcium concentration in single peritoneal macrophages. J Immunol. 1991, 147: 980-983.PubMed Letari O, Nicosia S, Chiavaroli C, Vacher P, Schlegel W: Activation by bacterial lipopolysaccharide causes changes in the cytosolic free calcium concentration in single peritoneal macrophages. J Immunol. 1991, 147: 980-983.PubMed
74.
go back to reference Zhou X, Yang W, Li J: Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappa B activation, inducible nitric oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem. 2006, 281: 31337-31347. 10.1074/jbc.M602739200.PubMedCrossRef Zhou X, Yang W, Li J: Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappa B activation, inducible nitric oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem. 2006, 281: 31337-31347. 10.1074/jbc.M602739200.PubMedCrossRef
75.
go back to reference Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, Suganami T, Kamei Y, Tanaka H, Tajima N, Utsunomiya K, Ogawa Y, Furukawa T: Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem Biophys Res Commun. 2010, 398: 284-289. 10.1016/j.bbrc.2010.06.082.PubMedCrossRef Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, Suganami T, Kamei Y, Tanaka H, Tajima N, Utsunomiya K, Ogawa Y, Furukawa T: Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem Biophys Res Commun. 2010, 398: 284-289. 10.1016/j.bbrc.2010.06.082.PubMedCrossRef
Metadata
Title
Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite,5-(p-hydroxyphenyl-), 5-phenylhydantoin
Authors
Ryan Serra
Abdel-ghany Al-saidi
Nikola Angelov
Salvador Nares
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2010
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-7-48

Other articles of this Issue 1/2010

Journal of Inflammation 1/2010 Go to the issue